Your browser doesn't support javascript.
loading
Nurse practitioner-delivered cognitive-behavioral treatment as a novel implementation route for irritable bowel syndrome: A proof of concept.
Burton Murray, Helen; Weeks, Imani; Thurler, Andrea; Calabrese, Samantha; Kate Lapinel, Mary; Madva, Elizabeth N; Staller, Kyle; Keefer, Laurie; Kuo, Braden.
Afiliação
  • Burton Murray H; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
  • Weeks I; Center for Neurointestinal Health, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Thurler A; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Calabrese S; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Kate Lapinel M; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Madva EN; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Staller K; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Keefer L; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
  • Kuo B; Center for Neurointestinal Health, Massachusetts General Hospital, Boston, Massachusetts, USA.
Neurogastroenterol Motil ; 35(4): e14526, 2023 04.
Article em En | MEDLINE | ID: mdl-36661110
ABSTRACT

BACKGROUND:

Exposure-based cognitive-behavioral therapy (exposure-CBT) is efficacious for irritable bowel syndrome (IBS). However, few patients receive exposure-CBT due to a lack of behavioral health providers trained in brain-gut behavior therapies. Nurse practitioners (NPs) could fill a critical need for scalable delivery methods. In a pragmatic investigation of a 5-session NP-delivered exposure-CBT for adults with Rome IV-defined IBS, we evaluated treatment feasibility and acceptability and explored changes clinical outcomes.

METHODS:

Exposure-CBT was delivered as part of routine care involving four sessions every other week and a 2-month booster session. Patients could electively participate in an observational study including pre-, mid-, and post-treatment surveys and a post-treatment qualitative interview. Independently coded ratings of NP treatment protocol adherence and competence ratings were completed from audio recordings, rated on a 1 (not at all) to 5 (completely) scale.

RESULTS:

Twenty-five patients consented (ages 22-67 years; 76% female; 48% IBS-diarrhea predominant). There was high feasibility-adherence average = 4.1, NP competence average = 4.8, 72% treatment completion, 93% satisfaction scores ≥3. Treatment satisfaction was high (rated as 4/4 "very satisfied" by n = 9 and as 3/4 "mostly satisfied" by n = 5). There were improvements in clinical outcomes across treatment with large effects for IBS-symptom severity (-53%; Hedge's g = 1.0; 95% confidence interval [CI] = 0.5, 1.5) and IBS quality of life (+31%; Hedge's g = 0.8; 95% CI = 0.4, 1.2).

CONCLUSIONS:

NP-delivered exposure-CBT for IBS was initially feasible and acceptable with promising clinical improvements. Findings will inform a future NIH Stage 1B/ORBIT Phase IIB pilot randomized control trial.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Cognitivo-Comportamental / Síndrome do Intestino Irritável Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Cognitivo-Comportamental / Síndrome do Intestino Irritável Idioma: En Ano de publicação: 2023 Tipo de documento: Article